Physician profile
Brett A Roeder
NPI 1134116700
$499.42
in general payments reported to CMS, 2019-2025
9 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $202 · 2020: $28.59 · 2023: $25.29 · 2024: $125 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $268.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $149.50 | 2019-2024 | Collagenase Santyl, Grafix, Oasis |
| Mimedx Group, INC. | $97.30 | 2024-2025 | |
| Integra Lifesciences Corporation | $71.19 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Allergan, INC. | $43.56 | 2019 | |
| Tactile Systems Technology INC | $37.85 | 2019-2020 | |
| Hydrofera LLC | $36.17 | 2024 | Hydrofera Blue |
| Solventum Corporation | $25.90 | 2025 | Activ.A.C. |
| Convatec INC. | $19.00 | 2019 | |
| Hartmann USA, INC. | $18.95 | 2024 | Zetuvit Plus 10x10 P10 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Roeder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.